MODERN DIAGNOSIS AND TREATMENT OF SUPERFICIAL BLADDER TUMORS by Hinev, A. et al.
cripta Scientifica Medica, vol.28, Suppl.1,pp.147-148 
Copyright © Medical University, Varna, 1991 
MODERN DIAGNOSIS AND TREATMENT OF SUPERFICIAL 
BLADDER TUMORS 
A. Hinev, D. Gochev, V. Ajladunov, L. Ralichkova 
Clinic of Urology, Varna 
Almost two thirds of all newly discovered bladder tumors are in 
stage Tj S, T a or T'i. They are known es "superficial bladder tumors" 
(SBT) and are considered to be completely curable nowadays (1,3). 
Early diagnosis is based on the screening methods - compu-
terized urine cytology and suprapubic ultrasound. Cystoscopy, how-
ever, combined with multiple cold-cup biopsies, still remains the 
main diagnostic method. TU ultrasound gives the most precise infor-
mation about tumor stage and is superior to CT scan (5). The latter 
is usually applied in cases of invasive (T3-T4) bladder cancer. The re-
maining X-ray studies give very little information. Magnetic reson-
ance imaging is a sensible, but still very expensive method. The data 
from cytoflowmetry; cytogenetic analysis; the detection of the super-
ficial tumor markers; other serum and urine markers, etc.*, give im-
portant prognostic information. Patient's immune status 
(immunodiagnosis resp.) also gains an increasing significance (3). 
Modern therapy is usually combined. Transurethral operative 
methods (TuTUR and laser photocoagulation) are the most import-
ant of al! (6). Photodynamic laser therapy is very perspective in this 
aspect. Open surgical methods are applied more rarely nowadays. 
Radiotherapy and systemic chemotherapy are rarely used, too, be-
cause of their numerous side effects and tumor's resistance (1). 
Local chemotherapeutics and immunomodulators, however, used as 
an adjuvant therapy after TuTUR, seem to be very popular (1,3). 
Since 1985 till 1991 545 patients with bladder cancer have been 
treated in the Clinic of Urology, Varna. They present 56,4% of all 
urooncological diseases - i.e. bladder cancer takes the leading place 
among all urological neoplasms. 318 (58,4%) of all bladder tumors 
have been superficial. The diagnostic-curative algorithm, accepted 
in the Clinic, comprises the following methods and agents: 
After detailed anamnesis and physical examination, either an 
echography, or a cystoscopy is done at first. The latter method may 
follow X-ray or ultrasound, but is always obligatory and is usually 
combined by cold-cup biopsy. Chromocystoscopy with methylene 
blue may help the detection of C a i s and endophytic tumors. Cytology 
has a comparatively low sensitivity and is used rarely, mainly in the 
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follow-up period. Tumor stage may be accurately determined by IVP, 
cystoscopy and TU ultrasound. CT scan is useful when an involve­
ment of the bladder wall is suspected. The results of these studies 
build our therapeutic strategy. TuTUR (under TU ultrasound control) 
is the method of choice in cases of SBT. The trocar suprapubic tumor 
resection enlarges the limits of this method. Recently we apply ad­
juvant laseer photocoagulation of the resection site. This method is 
used separately, as well. Open surgery is applied rarely, only in spe­
cial cases. 
In order to define the adequate metaphylaxis, all prognostic data 
are carefully analysed.In this aspect the detection of the superficial 
ABO(H) blood group antigens is very helpful (4). 
Postoperatively, local chemotherapy by thio-TEPA, Mitomycin С 
and Farmorubicin is done. Local immunotherapy by BCG (Calgevax) 
is used since 1987 (1,2). In single cases we've also applied nonspe­
cific immunotherapy by Levamisol, as well as local (intratumoral) im­
munotherapy by Interferon. 
A total of 128 of our patients had 5-years follow-up. The general 
5-years survival among them was 64,3%, while among the patients 
with SBT it reached 91%. These data are close to those, cited in the 
literature - 76 and 88%, respectively (1). More important are 2 other 
parameters, however: the recurrence rate (RR) and the percentage 
of tumor progression (TP). We came to the conclusion that they both 
depend on a lot of factors of prognostic value. These factors may be 
combined by a multifactorial analysis which is superior to the stand­
ard statistical methods. The routine use of such an analysis and of a 
computer, that leads the whole dispensary control and metaphylaxis, 
are directly forthcoming. 
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